Clene (CLNN) vs Zhengye Biotechnology (ZYBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clene (CLNN) has outperformed Zhengye Biotechnology (ZYBT) over the past year, losing 56.8% versus a loss of 60.5%. Clene is the larger company by market cap ($55.2 million vs $54.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLNN | ZYBT |
|---|---|---|
| Share price | $3.88 | $1.15 |
| Market cap | $55.15M | $54.50M |
| 1-day change | -1.02% | -0.87% |
| YTD return | -33.22% | +0.87% |
| 1-year return | -56.78% | -60.54% |
| 5-year return | -96.82% | — |
| EPS (TTM) | $-3.52 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $8.01 |
| 52-week low | $3.25 | $0.616 |
| Distance from 52-week high | -71.26% | -85.64% |
| Average volume | 99.70K | 5.11M |
| Shares outstanding | 14.21M | 47.39M |
| Employees | — | 269 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Clene in Health Care and Zhengye Biotechnology in Healthcare.
About Zhengye Biotechnology
ZYBT stock →Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.
Healthcare · Drug Manufacturers - Specialty & Generic · 269 employees
CLNN vs ZYBT FAQ
Which is bigger, Clene or Zhengye Biotechnology?
Clene (CLNN) is larger, with a market capitalization of $55.15M compared with $54.50M for Zhengye Biotechnology (ZYBT).
Which stock has performed better over the past year, CLNN or ZYBT?
CLNN returned -56.78% over the past 12 months, compared with -60.54% for ZYBT (price return, excluding dividends). Past performance does not predict future results.
Are Clene and Zhengye Biotechnology in the same industry?
No. Clene is in the Health Care sector, while Zhengye Biotechnology is in Healthcare.